NCT03424005 2026-03-16
Morpheus-panBC
Hoffmann-La Roche
Phase 1/2 Recruiting
Clinical Trials
8 trialsNCT06844669 2026-03-03
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
Phase 2 Active not recruiting
NCT06818305 2025-12-11
EmFin-Nx
Jinling Hospital, China
Phase 2 Terminated
NCT05271162 2025-11-21
EMPACT
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 3 Recruiting
NCT06140108 2025-05-14
Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity
SINA Health Education and Welfare Trust
Phase 2/3 Completed
NCT06103279 2023-10-26
Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin
Ain Shams University
Phase 2/3 Unknown
NCT05200793 2022-01-21
Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome
Alexandria University
Phase 4 Unknown
NCT03008551 2019-07-15
Empagliflozin vs Metformin in PCOS
Hull University Teaching Hospitals NHS Trust
Phase 2/3 Completed